Targeted Medical Pharma, Inc.
TRGM
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Net Income | -581.50K | -237.80K | -546.20K | -1.68M | -1.48M |
| Total Depreciation and Amortization | 53.50K | 51.80K | 57.60K | 67.70K | 97.80K |
| Total Amortization of Deferred Charges | 87.10K | 87.10K | 93.70K | 77.10K | 77.10K |
| Total Other Non-Cash Items | 125.10K | -28.60K | -49.50K | 29.70K | 169.80K |
| Change in Net Operating Assets | 392.30K | 259.70K | 418.50K | 42.40K | 1.38M |
| Cash from Operations | 76.50K | 132.20K | -25.90K | -1.46M | 237.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 4.00K | -4.00K | -- |
| Cash from Investing | -- | -- | 4.00K | -4.00K | -- |
| Total Debt Issued | 100.00K | 0.00 | 0.00 | 1.85M | 0.00 |
| Total Debt Repaid | -114.50K | -133.00K | -179.90K | -173.10K | -266.50K |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.50K | -133.00K | -179.90K | 1.68M | -266.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.00K | -800.00 | -201.80K | 211.40K | -28.80K |
